Conditions: Brain Neoplasm; Malignant Brain Glioma
Interventions: Drug: Gadobenate Dimeglumine; Drug: Gadobutrol; Procedure: Magnetic Resonance Imaging
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
Feeds
47589 items (47589 unread) in 74 feeds
Acinar Cell Carcinoma
(297 unread)
Acinic Cell Carcinoma
(223 unread)
Adenoid Cystic Carcinoma
(955 unread)
Adrenal Gland Cancer
(4201 unread)
Ampulla Of Vater
(1085 unread)
Anal Cancer
(4722 unread)
Angiosarcoma
(1447 unread)
Appendix Cancer
(643 unread)
Bile Duct Cancer
(5915 unread)
Brain and CNS
(6299 unread)
Carcinoid
(2041 unread)
Endocrine/Neuroendocrine
(5143 unread)
Gall Bladder Cancer
(2178 unread)
Hemangioendothelioma
(637 unread)
Hepatoblastoma
(687 unread)
Pancreas
(653 unread)
Phyllodes
(366 unread)
PMP and Mucinous Tumors
(430 unread)
Rhabdomyosarcoma
(1847 unread)
Sarcoma
(7820 unread)
Trial - Brain Tumor (100 unread)
-
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
Posted: October 21st, 2019, 2:00pm GMT
-
Brain Areas of Time-To-Contact Perception: an Awake Surgery Study
Posted: October 16th, 2019, 2:00pm GMT
Condition: Brain Tumors
Interventions: Behavioral: Behavioral task; Procedure: Awake surgery; Other: Neurological assessment
Sponsor: University Hospital, Toulouse
Recruiting -
NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Posted: October 16th, 2019, 2:00pm GMT
Conditions: Metastatic Melanoma; Melanoma Brain Metastasis
Interventions: Device: NovoTTF-200A; Drug: Pembrolizumab
Sponsor: Eric Wong, MD
Not yet recruiting -
Central Pain Syndrome in Survivors of Head and Neck Cancer
Posted: October 16th, 2019, 2:00pm GMT
Condition: Head and Neck Cancer
Interventions: Device: IPC-1000; Device: Magnetic resonance imaging; Other: Correlative Studies
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Not yet recruiting -
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
Posted: October 10th, 2019, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Olaptesed pegol; Radiation: Radiotherapy
Sponsor: NOXXON Pharma AG
Recruiting -
Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study
Posted: October 7th, 2019, 2:00pm GMT
Conditions: Cerebral Metastases; Fluorescence Guided Surgery
Intervention: Procedure: microsurgical resection
Sponsors: Ramsay Générale de Santé; Dr Philippe METELLUS
Recruiting -
Abemaciclib + Pembrolizumab In Glioblastoma
Posted: October 7th, 2019, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Pembrolizumab; Drug: Abemaciclib
Sponsor: Dana-Farber Cancer Institute
Not yet recruiting -
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
Posted: October 4th, 2019, 2:00pm GMT
Condition: Glioblastoma Multiforme
Interventions: Drug: Valganciclovir Tablets; Drug: Temozolomide 120 mg; Radiation: Radiotherapy 60 Gy; Drug: Placebo oral tablet
Sponsors: Cecilia Soderberg-Naucler; Karolinska University Hospital; Karolinska Institutet
Recruiting -
Antisecretory Factor in Primary Glioblastoma 1
Posted: October 4th, 2019, 2:00pm GMT
Conditions: Glioblastoma; Cerebral Edema; Chemotherapy Effect
Intervention: Dietary Supplement: Salovum
Sponsors: Peter Siesjö; Region Skane; Lund University; Skane University Hospital; Lantmannen Medical AB
Not yet recruiting -
3D Printed Mask for GBM and Brain Mets
Posted: October 3rd, 2019, 2:00pm GMT
Condition: Brain Cancer
Interventions: Device: 3D-printed mask; Device: Thermoplastic mask
Sponsor: University Health Network, Toronto
Not yet recruiting -
Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease
Posted: October 3rd, 2019, 2:00pm GMT
Condition: Metastatic Malignant Neoplasm in the Brain
Interventions: Radiation: Single Fraction Stereotactic Radiosurgery; Radiation: Fractionated Stereotactic Radiosurgery; Procedure: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Not yet recruiting -
Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma
Posted: October 2nd, 2019, 2:00pm GMT
Condition: Brain Tumor Adult
Intervention: Genetic: FGL2 immunohisyochemistry
Sponsor: sohaila Essam
Not yet recruiting -
MEningioma Detection Using Non Contrast MRI TecHniquEs
Posted: October 2nd, 2019, 2:00pm GMT
Condition: Meningioma
Intervention: Other: FABIR sequence
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Not yet recruiting -
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
Posted: October 2nd, 2019, 2:00pm GMT
Condition: Meningioma
Intervention: Other: sequences T1 FE
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Not yet recruiting -
Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases
Posted: October 1st, 2019, 2:00pm GMT
Condition: Brain Neoplasms
Intervention: Other: Diagnostic Amino acid PET/MRI examination
Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital; University of Bergen; Haukeland University Hospital; University of Tromso; University Hospital of North Norway
Not yet recruiting -
Psychological Intervention For Brain Tumor Caregivers
Posted: September 30th, 2019, 2:00pm GMT
Conditions: Malignant Glioma; Anxiety; Caregiver Burden
Interventions: Behavioral: Psychosocial Intervention Group; Behavioral: Usual Care Group
Sponsors: Massachusetts General Hospital; Conquer Cancer Foundation
Not yet recruiting -
A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
Posted: September 30th, 2019, 2:00pm GMT
Condition: CNS Metastases
Interventions: Other: Samples collection: Plasma; Other: Samples collection: CSF; Other: Samples collection: Non-CNS Metastatic Tumour Tissue; Other: Brain MRI
Sponsors: Jules Bordet Institute; La Fondation contre le cancer, Belgique; Les Amis de l'Institut Bordet; Bristol-Myers Squibb; Fondation Cancer, Luxembourg
Not yet recruiting -
PRolaCT - Three Multicenter Prolactinoma Randomized Clinical Trials
Posted: September 27th, 2019, 2:00pm GMT
Conditions: Prolactinoma; Prolactin-Producing Pituitary Tumor
Interventions: Procedure: Endoscopic trans-sphenoidal adenoma resection; Drug: Dopamine Agonists
Sponsor: Leiden University Medical Center
Recruiting -
Validation of a Quality of Life Metric "Prolac-10"
Posted: September 27th, 2019, 2:00pm GMT
Conditions: Prolactinoma; Prolactin-Producing Pituitary Tumor; Pituitary Tumor; Prolactinoma Macroadenoma; Prolactinoma Microadenoma
Intervention:
Sponsor: Ohio State University
Not yet recruiting -
Looking at Brain Changes in People With Lymphoma Receiving CAR-T Therapy
Posted: September 27th, 2019, 2:00pm GMT
Condition: Lymphoma Receiving CAR-T Therapy
Interventions: Behavioral: neurocognitive evaluations; Diagnostic Test: brain MRIs; Other: Blood samples
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting -
Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)
Posted: September 25th, 2019, 2:00pm GMT
Condition: Benign Neuronal Desease
Intervention: Device: cerebral MRI
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Not yet recruiting -
Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas
Posted: September 24th, 2019, 2:00pm GMT
Conditions: Leukemia; Brain Tumor; Sarcoma; Childhood Cancer; Cancer; Adolescent Cancer
Intervention: Other: Non-Interventional
Sponsor: Martin-Luther-Universität Halle-Wittenberg
Not yet recruiting -
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Posted: September 23rd, 2019, 2:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; High Grade Glioma
Interventions: Genetic: (C7R)-GD2.CART cells; Drug: Cyclophosphamide; Drug: Fludarabine
Sponsors: Baylor College of Medicine; Texas Children's Hospital; Center for Cell and Gene Therapy, Baylor College of Medicine
Not yet recruiting -
Mapping Draining Lymph Nodes in CNS Malignancies
Posted: September 20th, 2019, 2:00pm GMT
Conditions: Central Nervous System Neoplasms; Central Nervous System Tumor
Intervention: Drug: Tc-99m tilmanocept
Sponsor: Washington University School of Medicine
Not yet recruiting -
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI
Posted: September 20th, 2019, 2:00pm GMT
Condition: Glioma
Intervention: Other: PET/MRI
Sponsor: Imperial College London
Recruiting -
Heartrate Variability and Intraoperative Brain Conditions in Supratentorial Tumors
Posted: September 19th, 2019, 2:00pm GMT
Condition: Supratentorial Brain Tumors
Intervention: Device: ANSiscope
Sponsor: DyAnsys, Inc.
Recruiting -
Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
Posted: September 18th, 2019, 2:00pm GMT
Condition: Brain Metastases
Intervention: Drug: AGuIX
Sponsor: Centre Leon Berard
Not yet recruiting -
Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Posted: September 16th, 2019, 2:00pm GMT
Conditions: Glioma, Malignant; Gliosarcoma; Astrocytoma of Brain
Intervention: Drug: Intranasal Modified Temozolomide
Sponsor: Center Trials & Treatment Europe
Not yet recruiting -
Long-Term Longitudinal QoL in Patients Undergoing EEA
Posted: September 12th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor; Meningioma; Rathke Cleft Cysts; Chordoma; Chondrosarcoma; Craniopharyngioma; Encephalocele; Esthesioneuroblastoma
Intervention:
Sponsor: Ohio State University
Recruiting -
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Posted: September 11th, 2019, 2:00pm GMT
Condition: Brain Tumor
Interventions: Drug: Panitumumab-IRDye800; Device: Pinpoint-IR9000 endoscopic/handheld device; Device: Explorer Air camera; Device: PDE-NEO-II
Sponsor: Stanford University
Not yet recruiting -
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
Posted: September 10th, 2019, 2:00pm GMT
Condition: Brain Metastases
Interventions: Radiation: Radiation; Other: OSC
Sponsor: University Hospital Heidelberg
Recruiting -
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Posted: September 9th, 2019, 2:00pm GMT
Conditions: CNS Tumors; Meningioma; Esthesioneuroblastoma; Hemangioblastoma; Medulloblastoma; Paraganglioma; Pituitary Adenoma
Intervention: Diagnostic Test: Ga68-DOTATATE-PET/MRI
Sponsors: Weill Medical College of Cornell University; Novartis Pharmaceuticals
Recruiting -
Closed vs. Open Face Masks for Cranial Radiotherapy
Posted: September 5th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Metastases; Small Cell Lung Cancer; Meningioma
Intervention: Device: Head immobilization mask
Sponsor: University of Zurich
Not yet recruiting -
Multicentric Prospective Validation of the Zurich Pituitary Score
Posted: September 2nd, 2019, 2:00pm GMT
Condition: Pituitary Adenoma
Intervention:
Sponsor: University of Zurich
Not yet recruiting -
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
Posted: August 30th, 2019, 2:00pm GMT
Conditions: Primary Brain Tumor; Brain Metastases, Adult
Intervention: Other: Neuropsychological Testing
Sponsor: Duke University
Not yet recruiting -
Pilot Study of Abemaciclib With Bevacizumab in Recurrent Glioblastoma Patients With Loss of CDKN2A/B or Gain or Amplification of CDK4/6
Posted: August 30th, 2019, 2:00pm GMT
Conditions: GBM; Glioblastoma; Brain Tumor; Brain Tumor, Recurrent
Interventions: Drug: Abemaciclib; Drug: Bevacizumab
Sponsor: University of Texas Southwestern Medical Center
Not yet recruiting -
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Posted: August 30th, 2019, 2:00pm GMT
Conditions: Oncology; Breast Cancer; Prostate Cancer; Gynecologic Cancer; Brain Tumor; Brain Cancer; Gynecologic Tumor; Prostate Tumor; Prostate Neoplasm; Breast Tumor; Radiation Toxicity; Quality of Life; Rectal Cancer; Rectal Tumor; Rectal Neoplasms; Lung Cancer; Lung Tumor; Lung Neoplasm; Esophageal Cancer; Esophagus Cancer; Esophageal Tumor; Esophageal Neoplasm; Esophagus Tumor; Esophagus Neoplasm; Pancreatic Cancer; Pancreatic Tumor; Pancreatic Neoplasms; Head and Neck Cancer; Head and Neck Neoplasms; Head and Neck Tumor; Tumor; Neoplasms; Bladder Cancer; Bladder Neoplasm; Liver Cancer; Liver Neoplasms; Liver Metastases; Oligometastases
Intervention: Radiation: Radiation therapy
Sponsors: UMC Utrecht; The Netherlands Cancer Institute; Sunnybrook Health Sciences Centre; M.D. Anderson Cancer Center; The Christie NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Medical College of Wisconsin; Elekta
Recruiting -
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
Posted: August 30th, 2019, 2:00pm GMT
Condition: Pituitary Adenoma
Intervention: Procedure: Neurosurgery
Sponsor: Centre Hospitalier Universitaire de Nice
Not yet recruiting -
Stereotactic Radiosurgery Added to Binimetinib and Encorafenib in Patients With BRAFV600 Melanoma With Brain Metastasis
Posted: August 29th, 2019, 2:00pm GMT
Condition: Brain-only Metastased BRAFV600 Melanoma
Interventions: Radiation: Stereotaxic radiosurgery (SRS); Drug: Binimetinib Oral Tablet; Drug: Encorafenib Oral Capsule
Sponsors: UNICANCER; EADO - European Association of Dermato Oncology
Not yet recruiting -
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
Posted: August 29th, 2019, 2:00pm GMT
Conditions: Brain Metastases; Neurocognitive Deficit; White Matter Alterations; Radiation Exposure
Intervention:
Sponsor: UNC Lineberger Comprehensive Cancer Center
Recruiting -
Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
Posted: August 27th, 2019, 2:00pm GMT
Conditions: Malignant Neoplasm, Brain; Brain Tumor
Interventions: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Stereotactic Radiosurgery; Procedure: Therapeutic Conventional Surgery
Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI)
Not yet recruiting -
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer
Posted: August 26th, 2019, 2:00pm GMT
Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Health Care Provider; Malignant Brain Neoplasm; Malignant Genitourinary System Neoplasm; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Pancreatic Cancer; Stage IVA Prostate Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Pancreatic Cancer; Stage IVB Prostate Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8
Interventions: Procedure: Biospecimen Collection; Other: Genetic Testing; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting -
Neurocognitive Function After Proton Therapy in Children and Adolescents
Posted: August 23rd, 2019, 2:00pm GMT
Condition: Primary Brain Tumor
Intervention:
Sponsors: Technische Universität Dresden; Gert und Susanna Mayer Stiftung
Not yet recruiting -
A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Posted: August 22nd, 2019, 2:00pm GMT
Conditions: Glioma; Pilocytic Astrocytoma; Pilomyxoid Astrocytoma; Pleomorphic Xanthoastrocytoma; Ganglioglioma; Optic Pathway Glioma; Diffuse Astrocytoma
Intervention: Radiation: Hippocampal-avoidance proton therapy
Sponsor: St. Jude Children's Research Hospital
Recruiting -
A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Posted: August 21st, 2019, 2:00pm GMT
Condition: Extensive Stage Small Cell Lung Cancer
Interventions: Drug: HLX10; Drug: carboplatin and etoposide; Drug: placebo
Sponsor: Shanghai Henlius Biotech
Recruiting -
nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
Posted: August 20th, 2019, 2:00pm GMT
Conditions: Metastatic Malignant Neoplasm in the Brain; Radiation Therapy Recipient
Interventions: Behavioral: Hand Function Test; Procedure: Navigated Transcranial Magnetic Stimulation; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting -
FSRT in Breast Cancer Patients With Brain Metastases
Posted: August 19th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Brain Metastases
Intervention: Radiation: Fractionated stereotactic radiotherapy(FSRT)
Sponsor: Fudan University
Recruiting -
A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
Posted: August 15th, 2019, 2:00pm GMT
Conditions: Non Small Cell Lung Cancer; Brain Metastases
Interventions: Drug: Icotinib; Radiation: SRS/WBRT/HA-WBRT/SMART
Sponsor: Betta Pharmaceuticals Co., Ltd.
Recruiting -
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Posted: August 14th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Glioma
Interventions: Device: Orbeye surgical videomicroscope; Drug: 5-Aminolevulinic Acid
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Olympus Corporation
Recruiting -
An Early Phase 1 Trial of Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
Posted: August 9th, 2019, 2:00pm GMT
Conditions: Glial Tumor of Brain; Diffuse Intrinsic Pontine Glioma; Glioma
Interventions: Drug: Gemcitabine; Procedure: Tumor biopsy and blood draw
Sponsors: University of Michigan Rogel Cancer Center; University of Colorado, Denver
Not yet recruiting -
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Posted: August 8th, 2019, 2:00pm GMT
Conditions: Glioblastoma; Medulloblastoma; Ependymoma; Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Indoximod; Radiation: Partial Radiation; Radiation: Full-dose Radiation; Drug: Temozolomide; Drug: Cyclophosphamide; Drug: Etoposide; Drug: Lomustine
Sponsors: Theodore S. Johnson; National Cancer Institute (NCI); Augusta University; Emory University
Recruiting -
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
Posted: August 7th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Metastases; Brain Cancer
Intervention: Radiation: Reduced Dose SRS
Sponsor: Indiana University
Recruiting -
Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Posted: August 6th, 2019, 2:00pm GMT
Condition: Microdialysis
Intervention: Device: Intraoperative cerebral microdialysis using M dialysis 107 pump and 71 High cut-off brain microdialysis catheter
Sponsor: Mayo Clinic
Not yet recruiting -
CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma
Posted: August 6th, 2019, 2:00pm GMT
Conditions: Astrocytoma; Glioblastoma
Intervention: Drug: CC-90010
Sponsor: Celgene
Not yet recruiting -
Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors
Posted: August 5th, 2019, 2:00pm GMT
Conditions: Intracranial Neoplasm; Low Grade Glioma; Recurrent Glioblastoma; Recurrent World Health Organization (WHO) Grade II Glioma; Recurrent WHO Grade III Glioma
Interventions: Drug: F-18 Fluoroethyltyrosine (FET); Procedure: Positron Emission Tomography (PET)
Sponsor: Thomas Hope
Recruiting -
Body Image and Self-esteem in Adolescence
Posted: August 2nd, 2019, 2:00pm GMT
Condition: Body Image
Interventions: Other: Body Image evaluation; Other: Self esteem evaluation
Sponsor: Meyer Children's Hospital
Recruiting -
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Posted: August 2nd, 2019, 2:00pm GMT
Conditions: Pituitary; Pituitary Tumor; Pituitary Carcinoma; Pituitary Cancer
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting -
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Posted: August 1st, 2019, 2:00pm GMT
Condition: Brain Metastases
Intervention: Drug: Glucocorticoids
Sponsor: Medical University of Vienna
Not yet recruiting -
Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
Posted: July 31st, 2019, 2:00pm GMT
Condition: Brain Metastases
Intervention: Device: intraoperative radiotherapy (IORT)
Sponsor: University of Louisville
Not yet recruiting -
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
Posted: July 26th, 2019, 2:00pm GMT
Condition: Brain Tumor
Intervention: Device: MRI
Sponsor: Dana-Farber Cancer Institute
Not yet recruiting -
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
Posted: July 26th, 2019, 2:00pm GMT
Conditions: Cognitive Decline; Chemo-brain
Intervention: Drug: Memantine
Sponsors: UNC Lineberger Comprehensive Cancer Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting -
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Posted: July 24th, 2019, 2:00pm GMT
Conditions: Breast Cancer; HER2-positive Breast Cancer; Triple Negative Breast Cancer; Hormone Receptor Positive Malignant Neoplasm of Breast; Inflammatory Breast Cancer; Metastatic Breast Cancer
Intervention: Device: MRI
Sponsors: Dana-Farber Cancer Institute; Conquer Cancer Foundation
Not yet recruiting -
The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Posted: July 22nd, 2019, 2:00pm GMT
Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Testing: Genome; Diagnostic Test: Testing: Transcriptome; Diagnostic Test: Testing: Proteome; Drug: Treatment: CAR-T
Sponsor: Taproot Health
Not yet recruiting -
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Posted: July 17th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Tumor, Recurrent; Brain Tumor, Refractory; Brain Tumor, Pediatric; Medulloblastoma; Medulloblastoma Recurrent; Medulloblastoma, Non-WNT/Non-SHH; Medulloblastoma, Non-WNT/Non-SHH, Group 3; Medulloblastoma, Non-WNT/Non-SHH, Group 4; Brain Cancer; CNS Cancer; CNS Tumor; CNS Neoplasm
Interventions: Drug: Prexasertib; Drug: Cyclophosphamide; Drug: Gemcitabine; Biological: filgrastim; Biological: peg-filgrastim
Sponsors: St. Jude Children's Research Hospital; Eli Lilly and Company
Recruiting -
Pituitary Adenoma and Serum Lipid
Posted: July 16th, 2019, 2:00pm GMT
Condition: Pituitary Adenoma 1, Acth-Secreting
Intervention:
Sponsor: Shandong Provincial Hospital
Not yet recruiting -
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Posted: July 15th, 2019, 2:00pm GMT
Condition: Brain Tumor, Pediatric
Intervention:
Sponsor: Capital Medical University
Recruiting -
The Impact of Endoscopic Pituitary Surgery on Nasal Function
Posted: July 15th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor; Endoscopic Surgery; Quality of Life; Function of Nose
Interventions: Procedure: Single nostril approach endoscopic transsphenoidal pituitary surgery; Procedure: Bilateral nostril approach endoscopic transsphenoidal pituitary surgery
Sponsors: Zhebao Wu; Shanghai Zhongshan Hospital; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; The First Affiliated Hospital of Nanchang University
Recruiting -
Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
Posted: July 10th, 2019, 2:00pm GMT
Condition: Recurrent Glioblastoma
Interventions: Drug: Pembrolizumab; Drug: SurVaxM; Drug: Sargramostim; Drug: Montanide ISA 51
Sponsor: Manmeet Ahluwalia, MD
Not yet recruiting -
Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
Posted: July 3rd, 2019, 2:00pm GMT
Condition: Glioblastoma
Intervention: Procedure: Maximal, safe resection of brain tumour
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting -
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
Posted: July 3rd, 2019, 2:00pm GMT
Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; High-Frequency Microsatellite Instability; Locally Advanced Urothelial Carcinoma; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Pancreatic Adenocarcinoma; Metastatic Urothelial Carcinoma; Mismatch Repair Deficiency; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; PD-L1 Positive; Progressive Disease; Recurrent Head and Neck Squamous Cell Carcinoma; Refractory Lung Non-Small Cell Carcinoma; Refractory Pancreatic Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage IIA Pancreatic Cancer AJCC v8; Stage IIB Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Unresectable Malignant Solid Neoplasm; Unresectable Melanoma; Unresectable Pancreatic Adenocarcinoma
Interventions: Biological: Pembrolizumab; Drug: Sonidegib
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Not yet recruiting -
Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost
Posted: July 3rd, 2019, 2:00pm GMT
Conditions: Primary CNS Lymphoma; Brain Lymphoma
Intervention: Radiation: A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
Sponsor: Chang Gung Memorial Hospital
Not yet recruiting -
Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases
Posted: June 28th, 2019, 2:00pm GMT
Conditions: Brain Metastases; Melanoma; Lung Cancer; Breast Cancer
Interventions: Drug: Dexamethasone; Drug: Metformin
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Milan
Not yet recruiting -
Anti-PD-1 +/- RT for MSI-H Solid Tumors
Posted: June 27th, 2019, 2:00pm GMT
Conditions: Microsatellite Instability High; Mismatch Repair Deficiency; Colorectal Cancer
Interventions: Combination Product: RT and Anti-PD-1; Drug: Anti-PD-1
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI); Cancer League of Colorado, Inc
Not yet recruiting -
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
Posted: June 24th, 2019, 2:00pm GMT
Condition: Glioblastoma
Intervention: Drug: Sacituzumab Govitecan
Sponsors: The University of Texas Health Science Center at San Antonio; Immunomedics, Inc.
Recruiting -
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer
Posted: June 24th, 2019, 2:00pm GMT
Conditions: Small Cell Lung Cancer; Brain Metastases
Intervention: Device: Optune®-Tumor Treating Fields (TTFields)
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; NovoCure Ltd.
Not yet recruiting -
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
Posted: June 21st, 2019, 2:00pm GMT
Conditions: CDK Gene Mutation; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Solid Neoplasm; NTRK Family Gene Mutation; PI3K Gene Mutation; ROS1 Gene Mutation
Interventions: Drug: Abemaciclib; Drug: PI3K Inhibitor GDC-0084; Drug: Entrectinib
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Genentech, Inc.
Recruiting -
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Posted: June 19th, 2019, 2:00pm GMT
Conditions: Central Nervous System Sarcoma; Ependymoma; Glioma; Malignant Intracranial Germ Cell Tumor; Medulloblastoma; Pineoblastoma; Primary Central Nervous System Neoplasm
Interventions: Other: Placebo; Other: Questionnaire Administration; Drug: Wound Dressing Material
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting -
[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
Posted: June 18th, 2019, 2:00pm GMT
Condition: Glioma Glioblastoma Multiforme
Intervention: Drug: Axumin, Intravenous Solution
Sponsors: Seyed Ali Nabavizadeh, MD; Blue Earth Diagnostics
Not yet recruiting -
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Posted: June 17th, 2019, 2:00pm GMT
Condition: Pediatric Recurrent Brain Tumor
Interventions: Biological: Personalized neoantigen DNA vaccine; Device: TDS-IM System; Procedure: Peripheral blood draw
Sponsors: Washington University School of Medicine; Children's Discovery Institute
Not yet recruiting -
Impact of nrTMS Therapy on the Progress of Neurorehabilitation
Posted: June 11th, 2019, 2:00pm GMT
Condition: Transcranial Magnetic Stimulation, Repetitive
Interventions: Device: navigated repetitive transcranial magnetic stimulation; Procedure: physical therapy
Sponsor: Technische Universität München
Recruiting -
FBY PET/CT in Patients With Brain Tumors
Posted: June 10th, 2019, 2:00pm GMT
Condition: Brain Tumor
Intervention: Diagnostic Test: FBY-PET Examination Group: Patients receive FBY-PET examination after entrance
Sponsors: Peking Union Medical College Hospital; Peking University; Beijing Cancer Hospital
Recruiting -
Study on Physical Activity's Relationship With Cancer and Cognition
Posted: June 10th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Breast Neoplasm Female
Intervention: Behavioral: Walking
Sponsor: University of Nebraska
Recruiting -
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Posted: June 7th, 2019, 2:00pm GMT
Condition: Metastatic NRAS Melanoma
Interventions: Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 1); Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 2); Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 3)
Sponsor: Hospices Civils de Lyon
Not yet recruiting -
Feasibility of 11C-MET PET/MRI Imaging in Pediatric Brain Fossa Tumors
Posted: June 6th, 2019, 2:00pm GMT
Condition: Posterior Brain Fossa Tumors in Children
Intervention: Procedure: 11C-MET PET/MRI
Sponsor: Hospices Civils de Lyon
Not yet recruiting -
Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients
Posted: June 5th, 2019, 2:00pm GMT
Conditions: Cerebellar Function; Transcranial Magnetic Stimulation; Language Disorders
Intervention: Combination Product: Transcranial magnetic stimulation
Sponsors: Huashan Hospital; Shanghai Jing'an Central Hospital; Huashan Hospital North Hospital
Recruiting -
Pediatric Long-Term Follow-up and Rollover Study
Posted: June 5th, 2019, 2:00pm GMT
Conditions: Diffuse Astrocytoma; Anaplastic Astrocytoma; Astrocytoma; Oligodendroglioma, Childhood; Anaplastic Oligodendroglioma; Glioblastoma; Pilocytic Astrocytoma; Giant Cell Astrocytoma; Pleomorphic Xanthoastrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Angiocentric Glioma; Chordoid Glioma of Third Ventricle; Gangliocytoma; Ganglioglioma; Anaplastic Ganglioglioma; Dysplastic Gangliocytoma of Cerebrellum; Desmoplastic Infantile Astrocytoma and Ganglioglioma; Papillary Glioneuronal Tumor; Rosette-forming Glioneurona Tumor; Central Neurocytoma; Extraventricular Neurocytoma; Cerebellar Liponeurocytoma; Neurofibromatosis Type 1
Interventions: Drug: dabrafenib; Drug: trametinib
Sponsor: Novartis Pharmaceuticals
Not yet recruiting -
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Posted: June 4th, 2019, 2:00pm GMT
Conditions: High Grade Glioma; BRAF V600E; BRAF V600K; Anaplastic Astrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Gliosarcoma; Glioblastoma
Interventions: Drug: Encorafenib; Drug: Binimetinib; Biological: Research Bloods; Biological: Tumor Tissue
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI); Array BioPharma
Not yet recruiting -
Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
Posted: June 4th, 2019, 2:00pm GMT
Condition: Malignant Glioma
Interventions: Biological: PVSRIPO; Drug: Atezolizumab
Sponsors: Darell D. Bigner, MD, PhD; Istari Oncology, Inc.; Genentech, Inc.
Not yet recruiting -
Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
Posted: June 4th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor; Endocrine Neoplasia; Hyperparathyroidism; Solid Tumor; Familial Tumor Syndrome
Intervention: Other: Registration of familial forms and associated neoplasia
Sponsor: Neuromed IRCCS
Not yet recruiting -
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
Posted: June 3rd, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Cancer; Skull Base Tumor
Intervention:
Sponsor: Baptist Health South Florida
Recruiting -
Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma
Posted: June 3rd, 2019, 2:00pm GMT
Condition: Glioma
Intervention: Biological: Blood sample
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting -
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Posted: June 3rd, 2019, 2:00pm GMT
Conditions: High Grade Glioma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioblastoma
Interventions: Drug: Regadenoson 0.05mg; Drug: Regadensoson 0.1mg; Drug: Regadensoson 0.2mg; Drug: Regadensoson 0.4mg; Drug: Regadensoson 0.7mg; Drug: Regadensoson 1.0mg; Drug: Regadensoson 1.4mg
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI)
Not yet recruiting -
Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors
Posted: May 31st, 2019, 2:00pm GMT
Condition: Brain Tumor, Primary
Intervention: Procedure: brain tumor resection
Sponsors: University Hospital, Tours; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting -
A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Posted: May 30th, 2019, 2:00pm GMT
Condition: Neoplasms
Intervention: Drug: BXQ-350
Sponsors: Bexion Pharmaceuticals, Inc.; CTI Clinical Trial and Consulting Services
Recruiting -
A Phase 2 Study of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases
Posted: May 30th, 2019, 2:00pm GMT
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Cabozantinib
Sponsor: Centre Leon Berard
Not yet recruiting -
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Posted: May 29th, 2019, 2:00pm GMT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: BGB 324 (before surgery); Drug: BGB 324 (after surgery)
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI)
Not yet recruiting -
Resting-State Functional MRI in Glioma Patients Before and After Surgery
Posted: May 27th, 2019, 2:00pm GMT
Conditions: Brain Mass; Glioma
Interventions: Procedure: Functional Magnetic Resonance Imaging; Procedure: Magnetic Resonance Imaging; Procedure: Resting State Functional Connectivity Magnetic Resonance Imaging
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Posted: May 21st, 2019, 2:00pm GMT
Conditions: Glioblastoma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Malignant Glioma
Intervention: Radiation: Stereotactic Radiosurgery
Sponsor: Northwell Health
Recruiting -
A Multicentric Phase II, Open-label Study Evaluating the Efficacy of the Combination of Hypofractionated Stereotactic Radiation Therapy With the Anti-PDL1 Immune Checkpoint Inhibitor Durvalumab in NSCLC Patients With 1 to 4 Brain Metastases
Posted: May 20th, 2019, 2:00pm GMT
Conditions: Brain Metastases; NSCLC
Interventions: Radiation: Radiotherapy; Combination Product: Radiotherapy + durvalumab
Sponsor: Institut Claudius Regaud
Not yet recruiting -
Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children
Posted: May 17th, 2019, 2:00pm GMT
Conditions: Recurrent Brain Tumor, Childhood; Ketogenic Diet
Intervention: Other: Strict Classic Ketogenic Diet
Sponsor: Daniel Bowers
Not yet recruiting